Why Did the Takeover Bid for Comvita Limited Fail and Whats Next

Nov 14, 2025

Highlights:

  • Comvita Limited (NZX: CVT) shareholders rejected the NZ$0.80-per-share Florenz takeover bid, with early proxy votes indicating the proposal would not meet the required 75% approval threshold.
  • At the time of writing, the board has confirmed the deal is “very unlikely to proceed”, shifting its focus toward securing new capital to strengthen the company’s financial position.
  • The failed bid now puts pressure on Comvita’s management, as they navigate soft mānuka-honey market conditions, oversupply challenges and the need to reassure investors about the company’s future direction.

Shareholders Reject Major Offer

At the time of writing, Comvita Limited (NZX: CVT) has had its proposed takeover by Florenz voted down by shareholders, leaving the board to pivot quickly toward raising fresh capital. The offer, valued at NZ$0.80 per share, was put to a special meeting after extensive preliminary voting suggested insufficient support.

What Unfolded at the Meeting

The vote took place following a campaign that already indicated trouble for the scheme. Proxy voting had reached more than 80% participation, with early tallies showing only around 54% backing the deal — well short of the 75% threshold needed for approval. The board, chaired by Bridget Coates, acknowledged the result was “very likely not to proceed” while the final count and court approvals are still pending.

Next Step: Capital Raise in Focus

With the takeover off the table, Comvita’s leadership is now considering alternative funding options to shore up its balance sheet. The company faces headwinds in the mānuka-honey sector, including oversupply and price pressure. Investors will be watching closely how the board approaches the capital raise: whether via equity, subordinated debt or other methods — each of which carries implications for shareholder value and future strategy.

What It Means Going Forward

The failed takeover signals a critical juncture for Comvita. Without the certainty of a change in ownership and an injection of fresh capital, the company may face increased pressure from its global operations, supply chain challenges and margins under strain. The board now must persuade shareholders and the market that the business can stabilise and grow without major external help. As the final vote counts emerge and funding decisions crystallise, clarity will be key to rebuilding confidence.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com